SOTERA HEALTH COMPANY Basic Shares Outstanding (Weighted Average)
SOTERA HEALTH COMPANY (SHC) reported Basic Shares Outstanding (Weighted Average) of 285.77 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 285.77M shares, a 0.65% increase year-over-year.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 284.89M shares, a 0.47% increase year-over-year.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 284.26M shares, a 0.35% increase year-over-year.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 284.07M shares, a 0.36% increase year-over-year.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, basic for fiscal 2025 was 283.96M shares, a 0.41% increase from fiscal 2024.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, basic for fiscal 2024 was 282.78M shares, a 0.63% increase from fiscal 2023.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, basic for fiscal 2023 was 281.01M shares, a 0.33% increase from fiscal 2022.
- SOTERA HEALTH COMPANY weighted average number of shares outstanding, basic for fiscal 2022 was 280.10M shares, a 0.31% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 285.77M shares 10-Q · filed 2026-08-06 | 285.33M shares 10-Q · filed 2026-08-06 | 284.97M shares derived: average of 3 quarters · filed 2026-08-06 | 284.75M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 284.89M shares 10-Q · filed 2026-05-05 | 284.57M shares derived: average of 2 quarters · filed 2026-05-05 | 284.40M shares derived: average of 3 quarters · filed 2026-05-05 | 284.29M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 284.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 284.16M shares derived: average of 2 quarters · filed 2026-02-24 | 284.09M shares derived: average of 3 quarters · filed 2026-08-06 | 283.96M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 284.07M shares 10-Q · filed 2025-11-04 | 284.00M shares derived: average of 2 quarters · filed 2026-08-06 | 283.86M shares 10-Q · filed 2025-11-04 | 283.71M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 283.93M shares 10-Q · filed 2026-08-06 | 283.75M shares 10-Q · filed 2026-08-06 | 283.58M shares derived: average of 3 quarters · filed 2026-08-06 | 283.45M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 283.56M shares 10-Q · filed 2026-05-05 | 283.41M shares derived: average of 2 quarters · filed 2026-05-05 | 283.29M shares derived: average of 3 quarters · filed 2026-05-05 | 283.19M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 283.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 283.16M shares derived: average of 2 quarters · filed 2026-02-24 | 283.07M shares derived: average of 3 quarters · filed 2026-02-24 | 282.78M shares 10-K · filed 2026-02-24 |
| 2024-09-30 | 283.06M shares 10-Q · filed 2025-11-04 | 282.98M shares derived: average of 2 quarters · filed 2025-11-04 | 282.62M shares 10-Q · filed 2025-11-04 | 282.30M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 282.89M shares 10-Q · filed 2025-08-08 | 282.40M shares 10-Q · filed 2025-08-08 | 282.05M shares derived: average of 3 quarters · filed 2026-02-24 | 281.81M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 281.91M shares 10-Q · filed 2025-05-01 | 281.63M shares derived: average of 2 quarters · filed 2026-02-24 | 281.45M shares derived: average of 3 quarters · filed 2026-02-24 | 281.31M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 281.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 281.22M shares derived: average of 2 quarters · filed 2026-02-24 | 281.11M shares derived: average of 3 quarters · filed 2026-02-24 | 281.01M shares 10-K · filed 2026-02-24 |
| 2023-09-30 | 281.11M shares 10-Q · filed 2024-11-05 | 281.00M shares derived: average of 2 quarters · filed 2024-11-05 | 280.90M shares 10-Q · filed 2024-11-05 | 280.78M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 280.89M shares 10-Q · filed 2024-08-05 | 280.79M shares 10-Q · filed 2024-08-05 | 280.67M shares derived: average of 3 quarters · filed 2025-02-27 | 280.54M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 280.69M shares 10-Q · filed 2024-05-02 | 280.56M shares derived: average of 2 quarters · filed 2025-02-27 | 280.42M shares derived: average of 3 quarters · filed 2025-02-27 | 280.31M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 280.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 280.28M shares derived: average of 2 quarters · filed 2025-02-27 | 280.18M shares derived: average of 3 quarters · filed 2025-02-27 | 280.10M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 280.14M shares 10-Q · filed 2023-11-01 | 280.07M shares derived: average of 2 quarters · filed 2023-11-01 | 279.99M shares 10-Q · filed 2023-11-01 | 279.90M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 279.99M shares 10-Q · filed 2023-08-03 | 279.91M shares 10-Q · filed 2023-08-03 | 279.81M shares derived: average of 3 quarters · filed 2024-02-27 | 279.71M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 279.83M shares 10-Q · filed 2023-05-03 | 279.73M shares derived: average of 2 quarters · filed 2024-02-27 | 279.61M shares derived: average of 3 quarters · filed 2024-02-27 | 279.48M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 279.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 279.50M shares derived: average of 2 quarters · filed 2024-02-27 | 279.36M shares derived: average of 3 quarters · filed 2024-02-27 | 279.23M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 279.38M shares 10-Q · filed 2022-11-02 | 279.23M shares derived: average of 2 quarters · filed 2022-11-02 | 279.10M shares 10-Q · filed 2022-11-02 | 272.72M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | 279.08M shares 10-Q · filed 2022-08-04 | 278.95M shares 10-Q · filed 2022-08-04 | 270.50M shares derived: average of 3 quarters · filed 2023-02-28 | 260.97M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | 278.83M shares 10-Q · filed 2022-05-05 | 266.21M shares derived: average of 2 quarters · filed 2023-02-28 | 254.94M shares derived: average of 3 quarters · filed 2023-02-28 | 249.30M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | 253.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 242.99M shares derived: average of 2 quarters · filed 2023-02-28 | 239.46M shares derived: average of 3 quarters · filed 2023-02-28 | 237.70M shares 10-K · filed 2023-02-28 |
| 2020-09-30 | 232.40M shares 10-Q · filed 2021-11-10 | 232.40M shares derived: average of 2 quarters · filed 2021-11-10 | 232.40M shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 232.40M shares 10-Q · filed 2021-08-12 | 232.40M shares 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | 232.40M shares 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | 232.40M shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |